We suggest that the SH3YL1–NOX4 axis plays a critical role in the invasive phenotype of MIBC, distinguishing it from NMIBC at a molecular level and highlighting the need for targeted biomarkers in advanced bladder cancer. Here, NOX4 is linked to urinary bladder carcinoma.